Charles River Laboratories International, Inc. (CRL)
44.1Fair
ValueMarkers Composite Index
Top 16%#37,859 of 45,191
Overvalued
35% above intrinsic value ($118)
UndervaluedFair ValueOvervalued
Piotroski
4/9
NeutralBeneish
-2.86
Low RiskAltman
2.32
Grey ZoneDCF Value
$118
OvervaluedROIC
7.1%
LowP/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue
Deep Dive Analysis
DCF Analysis
Intrinsic value estimate, margin of safety, and key valuation metrics.
DCF: $117.96MOS: -35%Graham: $0.00
Piotroski F-Score
9-point financial strength test across profitability, leverage, and efficiency.
F-Score: 4/9
Quality Triple Check
Piotroski F-Score + Altman Z-Score + Beneish M-Score combined assessment.
F: 4/9Z: 2.3M: -2.9
Valuation Analysis
Complete multiples breakdown - P/E, P/B, EV/EBITDA, yield metrics, and intrinsic value.
P/B: 2.7EV/EBITDA: 14.2